1Agrawal R,Prelevic G,Conway GS,et a1.Serum vascular endothelial growth factor concentrations in postmenopausal women:the effect of hormone replacement therapy.Fertil Steril,2000,73:56～60.
2Ceballos C,Ribes C,Amado JA,et a1.Venous endothelial function in postmenopausal women who are receiving long-term estrogen and progestagen therapy.Fertil Steril,2000,74:268～273.
3Walsh BW,Paul S,Wild RA,et a1.The effect of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women:a randomized,controlled trial.J Clin Endocrinol Metab,2000.85:214～218.
4Cauley JA,Zmuda JM,EnsrudKE,et a1.Timing of estrogen replacement therapy for optimal osteoporosis prevention.J Clin Endoerinol Metah,2001,86:5700～5705.
5Smith YR,Giordani B,Lajiness-O’Neill R.et a1.Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women.Fertil Steril,2001,76:1101～1107.
6Freedman RR.Physiology and hot flashes.Am J Human Biol,2001,13:453～464.
7Kokcu A,Cetinkaya MB,Yanik F,et a1.The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women.Maturitas,2000.36:75～80.
8Hoibraaten E,Qvigstad E,Arnesen H,et a1.Increased risk of reeurrent venous thromboembolism during hormone replacement therapyresults of the randomized,double-blind, placebo-controlled estrogen in venous thromboembolism trial(EVTET).Thromb Haemost,2000,84:961～967.
9Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol,2001,85 : 877-- 882.
10Chowers I, Livni N, Frucht-Pery J, et al. Immunostaining of the estrogen receptor in conjunctival primary acquired melanosis. Ophthalmic Res, 1999.31:210--212.
